CHMP recommends approval of Pfizer's Covid-19 pill

Pfizer has received a positive opinion on its tablet treatment for Covid-19, Paxlovid, from the EMA’s expert committee. The pill was already in use in some countries, as the EMA had previously issued advice for emergency use of the unauthorized drug.


The European Medicines Agency’s (EMA) expert committee, the CHMP, has recommended that Pfizer’s Paxlovid, a treatment for Covid-19, be approved in the EU.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs